Record Information
Version1.0
StatusDetected and Quantified
Creation Date2020-12-10 18:37:47 UTC
Update Date2024-04-30 19:32:25 UTC
Metabolite IDMMDBc0000439
Metabolite Identification
Common Name12-HETE
Description12-Hydroxyeicosatetraenoic acid (CAS: 71030-37-0), also known as 12-HETE, is an eicosanoid, a 5-lipoxygenase metabolite of arachidonic acid. 5-Lipoxygenase (LO)-derived leukotrienes are involved in inflammatory glomerular injury. LO product 12-HETE is associated with the pathogenesis of hypertension and may mediate angiotensin II and TGFbeta induced mesangial cell abnormality in diabetic nephropathy. 12-HETE is markedly elevated in the psoriatic lesions. 12-HETE is a vasoconstrictor eicosanoid that contributes to high blood pressure in (renovascular) hypertension and pregnancy-induced hypertension. A significant percentage of patients suffering from a selective increase in plasma LDL cholesterol (type IIa hyperlipoproteinemia) exhibits increased platelet reactivity. This includes enhanced platelet responsiveness against a variety of platelet-stimulating agents ex vivo and enhanced arachidonic acid metabolism associated with increased generation of arachidonic acid metabolites such as 12-HETE, and secretion of platelet-storage products (PMID: 7562532 , 12480795 , 17361113 , 8498970 , 1333255 , 2119633 ). 12-HETE is a highly selective ligand used to label mu-opioid receptors in both membranes and tissue sections. The 12-S-HETE analog has been reported to augment tumour cell metastatic potential through activation of protein kinase C. 12-HETE has a diversity of biological actions and is generated by a number of tissues including the renal glomerulus and the vasculature. 12-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid. 12-HETE is a neuromodulator that is synthesized during ischemia. Its neuronal effects include attenuation of calcium influx and glutamate release as well as inhibition of AMPA receptor (AMPA-R) activation. 12-HETE is found to be associated with peroxisomal biogenesis defect and Zellweger syndrome, which are inborn errors of metabolism.
Structure
Synonyms
ValueSource
(12S)-12-Hydroxy-5,8,14-cis-10-trans-eicosatetraenoic acidChEBI
(5Z,8Z,10E,12S,14Z)-12-Hydroxyeicosa-5,8,10,14-tetraenoic acidChEBI
(5Z,8Z,10E,14Z)-(12S)-12-Hydroxyeicosa-5,8,10,14-tetraenoic acidChEBI
(5Z,8Z,10E,14Z)-(12S)-12-Hydroxyicosa-5,8,10,14-tetraenoic acidChEBI
12(S)-Hydroxy-5(Z),8(Z),10(e),14(Z)-eicosatetraenoic acidChEBI
12(S)-Hydroxy-5,8,14(Z),10(e)-eicosatetraenoic acidChEBI
12(S)-Hydroxyeicosatetraenoic acidChEBI
12S-HETEChEBI
(12S)-12-Hydroxy-5,8,14-cis-10-trans-eicosatetraenoateGenerator
(5Z,8Z,10E,12S,14Z)-12-Hydroxyeicosa-5,8,10,14-tetraenoateGenerator
(5Z,8Z,10E,14Z)-(12S)-12-Hydroxyeicosa-5,8,10,14-tetraenoateGenerator
(5Z,8Z,10E,14Z)-(12S)-12-Hydroxyicosa-5,8,10,14-tetraenoateGenerator
12(S)-Hydroxy-5(Z),8(Z),10(e),14(Z)-eicosatetraenoateGenerator
12(S)-Hydroxy-5,8,14(Z),10(e)-eicosatetraenoateGenerator
12(S)-HydroxyeicosatetraenoateGenerator
(5Z,8Z,10E,14Z)-12-Hydroxy-5,8,10,14-eicosatetraenoic acidHMDB
12(S)-HETEHMDB
12(S)-Hydroxy-5,8,14-cis-10-trans-eicosatetraenoic acidHMDB
12-Hydroxy-5,8,10,14-eicosatetraenoic acidHMDB
12-Hydroxy-5Z,8Z,10E,14Z-eicosatetraenoic acidHMDB
12-Hydroxyeicosatetraenoic acidHMDB
12-L-Hydroxy-5,8,10,14-eicosatetraenoic acidHMDB
12S-Hydroxy-5,8,10,14-(Z,Z,e,Z)-eicosatetraenoic acidHMDB
FA(20:4(5Z,8Z,10E,12-OH,14Z))HMDB
FA(20:4(5Z,8Z,10E,12S-OH,14Z))HMDB
Molecular FormulaC20H32O3
Average Mass320.4663
Monoisotopic Mass320.23514489
IUPAC Name(5Z,8Z,10E,12S,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoic acid
Traditional Name12S-hete
CAS Registry NumberNot Available
SMILES
CCCCC\C=C/C[C@H](O)\C=C\C=C/C\C=C/CCCC(O)=O
InChI Identifier
InChI=1S/C20H32O3/c1-2-3-4-5-10-13-16-19(21)17-14-11-8-6-7-9-12-15-18-20(22)23/h7-11,13-14,17,19,21H,2-6,12,15-16,18H2,1H3,(H,22,23)/b9-7-,11-8-,13-10-,17-14+/t19-/m0/s1
InChI KeyZNHVWPKMFKADKW-LQWMCKPYSA-N